Trends in the Assessment of Drug Supersaturation and Precipitation In Vitro Using Lipid-Based Delivery Systems.

The generation of drug supersaturation close to the absorptive site is an important mechanism of how several formulation technologies enhance oral absorption and bioavailability. Lipid-based formulations belong to the supersaturating drug delivery systems although this is not the only mechanism of how drug absorption is promoted in vivo. Different methods to determine drug supersaturation and precipitation from lipid-based formulations are described in the literature. Experimental in vitro setups vary according to their complexity and proximity to the in vivo conditions and, therefore, some tests are used for early formulation screening, while others better qualify for a later stage of development. The present commentary discusses this rapidly evolving field of in vitro testing with a special focus on the advancements in analytical techniques and new approaches of mechanistic modeling. The importance of considering a drug absorption sink is particularly emphasized. This commentary should help formulators in the pharmaceutical industry as well as in academia to make informed decisions on how to conduct in vitro tests for lipid-based delivery systems and to decide on the implications of experimental results.

[1]  Shan Ren,et al.  New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs , 2010, The Journal of pharmacy and pharmacology.

[2]  Martin Kuentz,et al.  Insights into Drug Precipitation Kinetics during In Vitro Digestion of a Lipid-Based Drug Delivery System Using In-Line Raman Spectroscopy and Mathematical Modeling , 2013, Pharmaceutical Research.

[3]  M. Kuentz,et al.  In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life , 2012, Drug development and industrial pharmacy.

[4]  Arik Dahan,et al.  The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[5]  Christopher J. H. Porter,et al.  Lipid-Based Formulations and Drug Supersaturation: Harnessing the Unique Benefits of the Lipid Digestion/Absorption Pathway , 2013, Pharmaceutical Research.

[6]  G. Amidon,et al.  The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation. , 2011, Molecular pharmaceutics.

[7]  M. Brewster,et al.  Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues. , 2013, International journal of pharmaceutics.

[8]  D. Mcclements,et al.  New mathematical model for interpreting pH-stat digestion profiles: impact of lipid droplet characteristics on in vitro digestibility. , 2015 .

[9]  K. Mäder,et al.  Monitoring of In Vitro Fat Digestion by Electron Paramagnetic Resonance Spectroscopy , 2006, Pharmaceutical Research.

[10]  Dallas B. Warren,et al.  In vitro digestion testing of lipid-based delivery systems: calcium ions combine with fatty acids liberated from triglyceride rich lipid solutions to form soaps and reduce the solubilization capacity of colloidal digestion products. , 2013, International journal of pharmaceutics.

[11]  Martin Bergstrand,et al.  PBPK models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[12]  Martin Kuentz,et al.  Toward an improved understanding of the precipitation behavior of weakly basic drugs from oral lipid-based formulations. , 2014, Journal of pharmaceutical sciences.

[13]  Christel A. S. Bergström,et al.  Models for Predicting Drug Absorption From Oral Lipid-Based Formulations , 2015, Current Molecular Biology Reports.

[14]  Thomas Rades,et al.  In Vitro Lipolysis Data Does Not Adequately Predict the In Vivo Performance of Lipid-Based Drug Delivery Systems Containing Fenofibrate , 2014, The AAPS Journal.

[15]  M. Khan,et al.  Preparation and in vitro characterization of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. , 2004, International journal of pharmaceutics.

[16]  A. Hoffman,et al.  Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the Relationship to Intra-Enterocyte Processes in Rats , 2006, Pharmaceutical Research.

[17]  Ben J. Boyd,et al.  Susceptibility to Lipase-Mediated Digestion Reduces the Oral Bioavailability of Danazol After Administration as a Medium-Chain Lipid-Based Microemulsion Formulation , 2004, Pharmaceutical Research.

[18]  M. Khan,et al.  Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. , 2001, International journal of pharmaceutics.

[19]  P. Gao,et al.  Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs , 2006, Expert opinion on drug delivery.

[20]  A. Müllertz,et al.  Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion. , 2012, Molecular pharmaceutics.

[21]  M. Khan,et al.  Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. , 2002, International journal of pharmaceutics.

[22]  Dallas B. Warren,et al.  Real time evolution of liquid crystalline nanostructure during the digestion of formulation lipids using synchrotron small-angle X-ray scattering. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[23]  F. Carrière,et al.  In Vitro Gastrointestinal Lipolysis of Four Formulations of Piroxicam and Cinnarizine with the Self Emulsifying Excipients Labrasol® and Gelucire® 44/14 , 2009, Pharmaceutical Research.

[24]  M. Kuentz Lipid-based formulations for oral delivery of lipophilic drugs. , 2012, Drug discovery today. Technologies.

[25]  P. Gao,et al.  Application of a biphasic test for characterization of in vitro drug release of immediate release formulations of celecoxib and its relevance to in vivo absorption. , 2010, Molecular pharmaceutics.

[26]  A. Dahan,et al.  The Solubility–Permeability Interplay and Its Implications in Formulation Design and Development for Poorly Soluble Drugs , 2012, The AAPS Journal.

[27]  Christel A. S. Bergström,et al.  Poorly soluble marketed drugs display solvation limited solubility. , 2007, Journal of medicinal chemistry.

[28]  Ping Gao,et al.  Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption. , 2009, Journal of pharmaceutical sciences.

[29]  M. Kuentz,et al.  Oral self-emulsifying drug delivery systems, from biopharmaceutical to technical formulation aspects , 2011 .

[30]  B. Griffin,et al.  Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations. , 2008, Advanced drug delivery reviews.

[31]  Mischa Bonn,et al.  Label-free imaging of lipophilic bioactive molecules during lipid digestion by multiplex coherent anti-Stokes Raman scattering microspectroscopy. , 2010, Journal of the American Chemical Society.

[32]  F. Carrière,et al.  Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters. , 2007, Biochimica et biophysica acta.

[33]  A. James 2010 , 2011, Philo of Alexandria: an Annotated Bibliography 2007-2016.

[34]  Thomas Rades,et al.  In Situ Lipolysis and Synchrotron Small-Angle X-ray Scattering for the Direct Determination of the Precipitation and Solid-State Form of a Poorly Water-Soluble Drug During Digestion of a Lipid-Based Formulation. , 2016, Journal of pharmaceutical sciences.

[35]  C. Pouton,et al.  An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations. , 2014, Molecular pharmaceutics.

[36]  Patrick Augustijns,et al.  Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? , 2009, Journal of pharmaceutical sciences.

[37]  Thomas Rades,et al.  Characterising Lipid Lipolysis and Its Implication in Lipid-Based Formulation Development , 2012, The AAPS Journal.

[38]  R Holm,et al.  Supersaturated Self-Nanoemulsifying Drug Delivery Systems (super-SNEDDS) , 2012 .

[39]  Georgios Imanidis,et al.  Advancing in‐vitro drug precipitation testing: new process monitoring tools and a kinetic nucleation and growth model , 2011, The Journal of pharmacy and pharmacology.

[40]  J. Reymond,et al.  In Vitro Model for Ciclosporin Intestinal Absorption in Lipid Vehicles , 1988, Pharmaceutical Research.

[41]  Martin Kuentz,et al.  Analytical technologies for real‐time drug dissolution and precipitation testing on a small scale , 2015, The Journal of pharmacy and pharmacology.

[42]  Hywel D Williams,et al.  Strategies to Address Low Drug Solubility in Discovery and Development , 2013, Pharmacological Reviews.

[43]  Ulf Olsson,et al.  Nucleation and crystal growth in supersaturated solutions of a model drug. , 2008, Journal of colloid and interface science.

[44]  C. Pouton,et al.  Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[45]  R. Löbenberg,et al.  Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs , 1998, Pharmaceutical Research.

[46]  C. Pouton,et al.  Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution. , 2009, Journal of pharmaceutical sciences.

[47]  Christopher J H Porter,et al.  Evaluation of the in‐vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products , 2002, The Journal of pharmacy and pharmacology.

[48]  A. Müllertz,et al.  In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems. , 2011, International journal of pharmaceutics.

[49]  J. Benneyan,et al.  Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[50]  Thomas Rades,et al.  Elucidating the Molecular Interactions Occurring during Drug Precipitation of Weak Bases from Lipid-Based Formulations: A Case Study with Cinnarizine and a Long Chain Self-Nanoemulsifying Drug Delivery System. , 2015, Molecular pharmaceutics.

[51]  J. Reymond,et al.  In Vivo Model for Ciclosporin Intestinal Absorption in Lipid Vehicles , 1988, Pharmaceutical Research.

[52]  Colin W Pouton,et al.  Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[53]  B. Griffin,et al.  Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[55]  D. Kashchiev,et al.  Review: Nucleation in solutions revisited , 2003 .

[56]  C. Pouton,et al.  Enhancing intestinal drug solubilisation using lipid-based delivery systems. , 2008, Advanced drug delivery reviews.

[57]  Lynne S Taylor,et al.  Enhancements and limits in drug membrane transport using supersaturated solutions of poorly water soluble drugs. , 2014, Journal of pharmaceutical sciences.

[58]  C. Porter,et al.  Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis. , 2001, Journal of pharmaceutical and biomedical analysis.

[59]  Martin Kuentz,et al.  Understanding interactions of oleic acid with basic drugs in solid lipids on different biopharmaceutical levels , 2014 .

[60]  T. Rades,et al.  Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate. , 2010, Journal of pharmaceutical sciences.

[61]  Thomas Rades,et al.  Supersaturated Self-Nanoemulsifying Drug Delivery Systems (Super-SNEDDS) Enhance the Bioavailability of the Poorly Water-Soluble Drug Simvastatin in Dogs , 2012, The AAPS Journal.

[62]  H. Kristensen,et al.  A dynamic in vitro lipolysis model. II: Evaluation of the model. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[63]  Ben J. Boyd,et al.  Drug Solubilization Behavior During in Vitro Digestion of Simple Triglyceride Lipid Solution Formulations , 2004, Pharmaceutical Research.

[64]  Christos Reppas,et al.  Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects , 2004, The Journal of pharmacy and pharmacology.

[65]  Martin Kuentz,et al.  Biopharmaceutical Modeling of Drug Supersaturation During Lipid-Based Formulation Digestion Considering an Absorption Sink , 2014, Pharmaceutical Research.

[66]  G. Edwards,et al.  In vitro-in vivo evaluation of lipid based formulations of the CETP inhibitors CP-529,414 (torcetrapib) and CP-532,623. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[67]  M. Kuentz,et al.  Critical concentrations in the dilution of oral self-microemulsifying drug delivery systems , 2010, Drug development and industrial pharmacy.

[68]  A. Müllertz,et al.  Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations. , 2012, Journal of pharmaceutical sciences.

[69]  L. S. Taylor,et al.  Liquid–Liquid Phase Separation in Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs: Implications for Solubility Enhancing Formulations , 2013 .

[70]  A Müllertz,et al.  A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[71]  A. Müllertz,et al.  Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 3: Understanding Supersaturation Versus Precipitation Potential During the In Vitro Digestion of Type I, II, IIIA, IIIB and IV Lipid-Based Formulations , 2013, Pharmaceutical Research.

[72]  Selena Di Maio,et al.  Effect of Ingested Lipids on Drug Dissolution and Release with Concurrent Digestion: A Modeling Approach , 2013, Pharmaceutical Research.

[73]  G. Edwards,et al.  Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems. , 2012, Molecular pharmaceutics.

[74]  M. Kuentz,et al.  Study of drug supersaturation for rational early formulation screening of surfactant/co‐solvent drug delivery systems , 2013, The Journal of pharmacy and pharmacology.

[75]  M. Kuentz,et al.  Application of a Statistical Method to the Absorption of a New Model Drug from Micellar and Lipid Formulations—Evaluation of Qualitative Excipient Effects , 2007, Pharmaceutical development and technology.

[76]  K. Kawakami,et al.  Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. , 2012, Advanced drug delivery reviews.

[77]  G. Edwards,et al.  Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. , 2004, Journal of pharmaceutical sciences.

[78]  P. Gao,et al.  Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. , 2003, Journal of pharmaceutical sciences.

[79]  G. Edwards,et al.  Increasing the Proportional Content of Surfactant (Cremophor EL) Relative to Lipid in Self-emulsifying Lipid-based Formulations of Danazol Reduces Oral Bioavailability in Beagle Dogs , 2007, Pharmaceutical Research.

[80]  M. Kuentz,et al.  A Systematic Dilution Study of Self-Microemulsifying Drug Delivery Systems in Artificial Intestinal Fluid Using Dynamic Laser Light Backscattering , 2009 .